Código QR (código de barras bidimensional)

Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma

Introduction: Cabozantinib has been approved by the European Medicine Agency (EMA) for hepatocellular carcinoma (HCC) previously treated with sorafenib. Cabozantinib is also being tested in combination with immune checkpoint inhibitors in the frontline setting. Real-life clinical data of cabozantini...

Fuld beskrivelse

Na minha lista:
Principais autores: Francesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, Lorenza Rimassa, Gianluca Masi, Massimo Iavarone, Fabio Marra, Ingrid Garajova, Maria Pia Brizzi, Bruno Daniele, Franco Trevisani, Carlo Messina, Francesco Di Clemente, Sara Pini, Giuseppe Cabibbo, Alessandro Granito, Mario Domenico Rizzato, Vittorina Zagonel, Giovanni Brandi, Tiziana Pressiani, Piera Federico, Caterina Vivaldi, Irene Bergna, Claudia Campani, Fabio Piscaglia
Format: Artigo
Sprog:Inglês
Udgivet: Karger Publishers 2021-06-01
Serier:Liver Cancer
Fag:
hepatocellular carcinoma
cabozantinib
sorafenib
tyrosine kinase inhibitors
outcome
Online adgang:https://www.karger.com/Article/FullText/515551
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker